Cimzia (UCB, Inc.)
Welcome to the PulseAid listing for the Cimzia drug offered from UCB, Inc.. This Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | UCB, Inc. |
| NON-PROPRIETARY NAME: | certolizumab pegol |
| SUBSTANCE NAME: | CERTOLIZUMAB PEGOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-05-14 |
| END MARKETING DATE: | 0000-00-00 |
Cimzia HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cimzia from UCB, Inc. |
| LABELER NAME: | UCB, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200(mg/mL) |
| START MARKETING DATE: | 2009-05-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 50474-710_02283a90-77a9-4af2-81c6-fec71632fb9e |
| PRODUCT NDC: | 50474-710 |
| APPLICATION NUMBER: | BLA125160 |
Other CERTOLIZUMAB PEGOL Pharmaceutical Manufacturers / Labelers:
